Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study

Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial

(2016) Elaheh Salardini et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Is serotonin transporter polymorphism (5-HTTLPR) allele status a predictor for obsessive-compulsive disorder? A meta-analysis

(2015) Lauren Mak et al.   Archives of Womens Mental Health

Managing obsessive compulsive disorder

(2015) Vlasios Brakoulias   Australian Prescriber

1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive–compulsive disorder: A case-control study

(2015) A.E. Ortiz et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Decreased thalamic glutamate level in unmedicated adult obsessive–compulsive disorder patients detected by proton magnetic resonance spectroscopy

(2015) Yajing Zhu et al.   JOURNAL OF AFFECTIVE DISORDERS

Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder

(2015) Christopher Pittenger et al.   JOURNAL OF CLINICAL PSYCHIATRY

Whole-genome association analysis of treatment response in obsessive-compulsive disorder

(2015) H Qin et al.   MOLECULAR PSYCHIATRY

Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial

(2015) M. Shalbafan et al.   PHARMACOPSYCHIATRY

The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis

(2015) Tord Ivarsson et al.   PSYCHIATRY RESEARCH

Amantadine Augmentation Therapy for Obsessive Compulsive Patients Resistant to SSRIs—An Open-Label Study

(2014) Rafael Stryjer et al.   CLINICAL NEUROPHARMACOLOGY

Ondansetron or placebo in the augmentation of fluvoxamine response over 8 weeks in obsessive–compulsive disorder

(2014) Mahnaz Heidari et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

The Effect of Riluzole Augmentation in a Patient With Treatment-Resistant Obsessive-Compulsive Disorder, Taking Two Other Glutaminergic Agents

(2014) Nahla Mahgoub et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Bilateral thermal capsulotomy with MR-guided focused ultrasound for patients with treatment-refractory obsessive-compulsive disorder: a proof-of-concept study

(2014) H H Jung et al.   MOLECULAR PSYCHIATRY

Obsessive-compulsive disorder

(2014) D. Veale et al.   BMJ-British Medical Journal

Glutamate drugs and pharmacogenetics of OCD: a pathway-based exploratory approach

(2013) Marco A Grados et al.   Expert Opinion on Drug Discovery

Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia

(2013) Farzin Rezaei et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Granisetron Adjunct to Fluvoxamine for Moderate to Severe Obsessive-Compulsive Disorder

(2012) Neda Askari et al.   CNS DRUGS

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials

(2012) Markus Dold et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study

(2012) Ali Ghaleiha et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The role of glutamate signaling in the pathogenesis and treatment of obsessive–compulsive disorder

(2011) Ke Wu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

A Single-Blinded Case-Control Study of Memantine in Severe Obsessive-Compulsive Disorder

(2010) S. Evelyn Stewart et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Memantine as an Augmenting Agent for Severe Pediatric OCD

(2009) DIANNE M. HEZEL et al.   AMERICAN JOURNAL OF PSYCHIATRY

N-Acetylcysteine, a Glutamate Modulator, in the Treatment of Trichotillomania

(2009) Jon E. Grant et al.   ARCHIVES OF GENERAL PSYCHIATRY

Memantine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder

(2009) Elias Aboujaoude et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Anti-Brain Autoantibodies and Altered Excitatory Neurotransmitters in Obsessive–Compulsive Disorder

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

Riluzole in the Treatment of Mood and Anxiety Disorders

(2008) Christopher Pittenger et al.   CNS DRUGS

Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1

(2007) Elena Fumagalli et al.   EUROPEAN JOURNAL OF PHARMACOLOGY